Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Phase II Neoadjuvant Chemotheraphy (Gemcitabine and Nab-Paclitaxel vs. mFOLFIRINOX) and Sterotatic Body Radiation Therapy for Borderline Resectable Pancreatic Cancer

Nathan Bahary, MD · 2014
ClinicalTrials.gov · Datasets · License: Public Domain · 2014
Open Source ↗
borderlinecancerpaclitaxel
borderline resectable pancreatic cancer, borderline, resectable, pancreatic, cancer, neoadjuvant, chemotheraphy, gemcitabine, nab-paclitaxel, mfofirinox, sterotatic body radiation therapy, interventional
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 810173
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.